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with degenerative encephalopathy, and indicated alteration of F1
biosynthesis [1]. The search in other cases for disease causing gene by
expression profiling and homozygosity mapping, identified mutation in
TMEM70 gene encoding a 30 kDa mitochondrial protein of unknown
function [2]. Enzyme defect was complemented by wtTMEM70 and
TMEM70protein turned out to be a novel ancillary factor of ATP synthase
biosynthesis, interestingly the first one specific for higher eukaryotes.
Homozygous TMEM70 c.317-2A>Gmutation leading to aberrant splicing
and loss of the TMEM70mRNAwas found in 24 patients, one patient was
compound heterozygote for c.118_119insGT frame-shift mutation. Since
then TMEM70mutations were found in other patients [3] thus being the
most frequent cause ofATP synthasedeficiency.Nevertheless, other cases
may exist where additional nuclear genes are involved.
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Autism is a severe pervasive developmental disorder characterized by
variable degrees of impairment in language, communication and social
skills, as well as by repetitive and stereotypic patterns of behaviour.
Despite strong familial components, clinical and genetic complexities
have posed a major challenge to our understanding of autism pathogen-
esis. A significant subset of autistic patients display biochemical or
neuropathological evidence of mitochondrial dysfunction and/or oxida-
tive stress. However, only in a very few cases abnormal energy
metabolism could be linked to a specific genetic defect. Interest in
assessing the role ofmitochondria in this disorder has been revitalized by
the association between autism and variants of the SLC25A12 gene [1],
which encodes the predominant isoform of themitochondrial aspartate/
glutamate carrier (AGC) in brain [2]. Cytosolic Ca2+ can rapidly activate
AGC transport through four “EF-hand”domains located at itsN-terminus,
thereby increasing the NADH/NAD ratio in themitochondrial matrix and
consequently boosting electron flow through the respiratory chain and
ATP generation by oxidative phosphorylation [3]. Post-mortem studies of
temporocortical gray matter from matched patient–control pairs
revealed that AGC transport rates were significantly higher in brains
from autistic patients [4]. This difference was blunted by Ca2+ chelator
EGTA and direct fluorimetric measurements confirmed significantly
higher Ca2+ levels in the patients, compared to their matched controls
[4]. Oxidized mitochondrial proteins were markedly increased in the
majority of the patients tested. Interestingly, oxidative damage correlated
with the reduction of complex I activity indicating that excessive Ca2+
levels boost AGC activity in neurons and, to amore variable degree, cause
oxidative stress and mitochondrial dysfunction in autistic brains.
Furthermore, we identified a protective SLC25A12 gene variant in a
sizable group of unaffected siblings modulating AGC1 mRNA levels and
protein activity. Our results suggest that mitochondria may play a critical
role in the cascade of signalling events leading to autism and in
determining to what extent different prenatal triggers will derange
neurodevelopment and yield abnormal postnatal behaviour.
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Heart failure is characterized by chronic, progressively worsening,
insufficient energy supply and failure of ventricular contraction for
the maintenance of blood circulation. We examined the abundance
and activity of crucial mitochondrial enzymes as potential contribu-
tors to heart failure. Human left ventricular tissue was biopsied from
non-failing donor hearts and end-stage failing hearts. Activity of
complexes I and IV, the NADH-linked Krebs enzymes isocitrate
dehydrogenase and malate dehydrogenase, NADPH transhydrogenase
and aconitase was lower in failing hearts, as determined spectro-
photometrically, while that of complexes II, III and citrate synthase
was unchanged. Specific protein expression of each of these,
determined by western blotting did not differ between the non-
failing and failing heart groups, implying post-translational protein
perturbation. Oxidative modification was explored as an underlying
cause of enzyme dysfunction. Of the three oxidative markers
measured, total mitochondrial protein carbonylation was greater by
31% in the failing tissues, while levels of 4-hydroxy-2-nonenal and
protein nitration did not differ. Isolation of complexes I, IV and V by
immunocapture revealed that subunits containing the iron–sulphur
or heme redox centers were targets of oxidative modification, which
may explain decreased activity in these enzymes. Notably the lower
level of mitochondrial activity in heart failure coincided with
significantly higher levels of oxidized glutathione, lower glutathione
reductase activity, and lower content of total Coenzyme Q10,
cardiolipin, total adenine nucleotides, NADH and NADPH. In conclu-
sion, the energy insufficiency of the failing human heart involves
impaired activity of key mitochondrial enzyme subunits, at least in
part due to oxidative modification. Thus the management of reactive
oxygen species which markedly deteriorates concomitant with
augmenting contractile failure may be a critical factor contributing
to spiralling energy deficiency in the failing human heart.
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Oxygen homeostasis is essential for normal cellular function; as
oxygen level decreases (hypoxia), cells respond by changing their
metabolism and by activating hypoxia-inducible factor dependent
gene transcription to adapt and survive. Mitochondria sense the
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oxygen level fall, change their morphology, dynamics, and function,
and play a major role in activating the cellular adapting mechanisms
[for recent reviews see 1, 2]. Although these mechanisms are
extremely important in pathophysiology, many of their aspects at
the molecular level are still elusive. In addition, most studies
concerning hypoxia have been carried out exposing to low oxygen
levels the experimental models (animals, organs, or cells) for several
hours only. Since our research group has a long experience in
studying the bioenergetics of hypoxia-associated pathophysiological
states, including aging [3, 4], heart and liver ischemia [5], cancer [6],
and Alzheimer Disease [7], we evaluated the hypothesis that the
mass, organization and function of mitochondria might be impaired
when cells are exposed to prolonged hypoxia under various
metabolic conditions. Therefore, as a first approach, we analyzed
oxygen dependence of mitochondrial mass and function in human
fibroblasts following 72 h exposition to variable oxygen pressure and
energy substrates. In presence of glucose as the main fuel, the
oligomycin-sensitive ATP synthesis rate of cells exposed to 1% O2
resulted greatly decreased with respect to controls exposed to air
(21% O2) or to oxygen levels (4–6% O2) corresponding to those
present in the extracellular liquid in humans. Structural analysis of
the 1% O2 exposed fibroblasts indicated a more fragmented state and
a decreased mass of the mitochondria than controls (i.e. exposed to
21% O2); the latter was confirmed by assaying the citrate synthase
activity of the cells exposed to different oxygen tensions. These
results will be discussed in relation with supramolecular organization
of the oxphos complexes in the mitochondrial inner membrane.
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Eukaryotic cytochrome c oxidase (CcO) is a hetero-oligomeric,
heme–copper oxidase complex composed of both mitochondrially and
nuclear-encoded subunits. CcO biogenesis is a complicated process that
requires numerous specific assembly factors including translational
activators, translocases, molecular chaperones, copper metallochaper-
ones, heme a biosynthetic enzymes. We present the results of clinical,
biochemical and molecular analyses in 107 CcO deficient children from
our department. Methods: The activities of respiratory chain complexes
were measured spectrophotometrically. The amount and protein
composition were studied by BN-PAGE western blotting. DNA sequen-
cing and PCR-RFLP were used for molecular analyses. Results:
Encephalopathy was present in 90% of children, Leigh syndrome in
20%, andcardiomyopathy in23%. IsolatedCcOdeficiencywas found in51
children and CcO deficiency combined with deficiency of other
complexes was found in 56. In children with isolated CcO deficiency,
SURF1 mutations were found in 15/51 children, SCO2 mutations in 12/
51, and SCO1mutation in one. Mutations c.845_846delCT in SURF1 and
g.1541G>A in SCO2wereprevalent. At the biochemical level, SCO1, SCO2
and SURF1 deficiency resulted in tissue specific pattern of CcO assembly
impairment that was not paralleled by corresponding reduction in the
particular proteins' levels. Moderate to profound decrease of cellular
copper was observed in muscle biopsies. MtDNAmutations were found
in 7 patients with combined CcO deficiency. Conclusion: CcO deficien-
cies represent a heterogeneous group of diseases. Isolated CcO
deficiency resulting from mutations in CcO assembly factors Surf1 and
Sco2 represents themost frequently recognized causes of CcO defects in
childhood. Owing to their incidence, absence of therapy and serious
social–economical consequences, elucidation of themolecular mechan-
isms is essential for diagnostics, prevention and development of future
therapeutic protocols. The reduced cellular copper levels of SCO1, SCO2
and SURF1 samples may indicate additional role of these CcO assembly
proteins in copper homeostasis maintenance. The particular tissue-
specific impact of SCO1, SCO2 and SURF1 deficiency suggests once again
highly tissue-specific nature of respiratory chain biogenesis.
Supported by MSM 0021620806 and IGA MZ 10581/3.
References
[1] Stiburek L et al. (2009) Am. J. Physiol. Cell Physiol. 296: C1218–226
[2] Vesela K et al. (2008) APMIS 116: 41–49
[3] Pejcnochova M et al. (2010) Mitochondrion.
doi:10.1016/j.bbabio.2010.04.162
Posters
4P.1 Detection of single large-scale mitochondrial DNA deletions
by MLPA technique
D. Piekutowska-Abramczuk1, A. Tanska1, P. Kowalski1, K. Tonska2,
E. Ciara1, D. Jurkiewicz1, M. Borucka-Mankiewicz1, S. Luczak1, M. Pelc1,
J. Sykut-Cegielska3, M. Krajewska-Walasek1, E. Bartnik2, E. Pronicka1
1Department of Medical Genetics, The Children's Memorial Health
Institute, Warsaw, Poland
2The Institute of Genetics and Biotechnology, University of Warsaw,
Poland
3Department of Metabolic Diseases, Endocrinology and Diabetology,
The Children's Memorial Health Institute, Warsaw, Poland
E-mail: d.abramczuk@czd.pl
Large-scale rearrangements consist of single partial mtDNA deletions
or, more rarely, partial duplications. They are heteroplasmic since they
coexist with variable amounts of wild-type mtDNA. Over 150 different
mtDNA deletions have been associated with known sporadic deletion
syndromes: Kearns–Sayre Syndrome (KSS), progressive external ophtal-
moplegia (PEO), and Pearson Syndrome (PS), although they may
occasionally be identified in patients with other mitochondrial cytopa-
thies (e.g. MELAS). The most common deletion responsible for almost
30% of deletion syndromes, contains 4977 bp and is located between
nucleotides m.8469 and m.13147. Characteristic clinical features asso-
ciated with large-scale mtDNA deletions include: progressive external
ophtalmoplegia, generalized muscle weakness with difficulties in
swallowing and articulation, short stature, deafness, conduct distur-
bances, delayedpuberty, and endocrine dysfunction. The aimof the study
was to characterize the role of the large-scale mtDNA deletions in the
pathogenesis of mitochondrial disease in selected patients. Fifteen
patients with mitochondrial cytopathies (including 5 KSS cases), and
seven controls (5 healthy subjects, and 2 patients with known
m.3243A>G mutation) were enrolled into our study. Blood samples
and muscle biopsies were used as DNA source in molecular analyses.
MLPA (Multiplex Ligation-dependent Probe Amplification) technique
was applied in the detection of deletions. SALSA MLPA KIT P125
Mitochondria (MRC-Holland) containing 31 probes for different mtDNA
sequences, and 1 mutation-specific probe for the frequent point
substitution m.3243A>G (MELAS) was used. Two various deletions
spanning regions: m.9169_14174 (ATP6, MTCOIII, MTND3–MTND6
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